The Kidney Failure Risk Equation (KFRE) was developed by nephrologists as a way to predict the likelihood that a person with chronic kidney disease will progress to kidney failure within a specific time frame, typically two or five years. The model incorporates measures of kidney function—such as estimated glomerular filtration rate (eGFR) and the albumin-to-creatinine ratio (ACR)—along with demographic factors like age and sex. By combining these variables using statistical regression, the equation produces a percentage that represents the risk of requiring dialysis or a kidney transplant in the near future. The higher the score, the closer monitoring and medical intervention may be warranted.
eGFR is a standard lab estimate of how efficiently your kidneys filter waste from the blood. Values below 60 mL/min/1.73m² are generally considered below normal and may indicate reduced kidney function. ACR measures how much albumin, a type of protein, leaks into the urine. Elevated protein levels often mean the kidneys are damaged, as they should retain most protein. Age and sex help tailor the model to the characteristics of the population used to build it. In general, older age or being male slightly increases risk, while higher eGFR decreases risk.
The mathematical formula for the simplified four-variable KFRE can be expressed using a logistic function:
where is a linear combination of your inputs. In this tool, the equation is simplified to:
Here, equals 1 for males and 0 for females. The output represents the probability (expressed as a percentage) of kidney failure within two years. It is important to note that published clinical models are often more complex, but this approximation captures the overall trend seen in research.
Chronic kidney disease affects millions of people worldwide. Early identification of those at highest risk of kidney failure allows doctors to implement interventions that may slow progression. These include tighter blood pressure control, dietary changes to limit salt and protein, and careful monitoring of medications. Knowing your risk can also help you plan for potential treatments such as dialysis or transplant. Use the calculator as a conversation starter with your healthcare provider.
After entering your information and clicking the estimate button, the calculator will display a percentage. A value near zero suggests a very low short-term risk, while a percentage above 20% typically signals significant concern. However, no tool can perfectly predict individual outcomes. Other factors—including race, genetic predisposition, and additional lab results—may modify your risk. Only your healthcare provider can interpret the score in the context of your entire medical history.
The KFRE was developed using specific patient populations, and its accuracy may vary in different demographic groups. Additionally, lab values can fluctuate from day to day, so a single test result may not tell the whole story. The equation assumes that eGFR and ACR are measured reliably and that other potential causes of kidney failure, such as polycystic kidney disease or autoimmune conditions, are not present. Because kidney disease can progress gradually, periodic testing and consultation with a specialist remain essential.
One of the strengths of the KFRE is its ability to track risk over time. If your eGFR steadily declines or your ACR increases, the calculated risk will rise accordingly. Conversely, lifestyle changes and medications that stabilize kidney function can lower the percentage. This dynamic view enables you to see how well your treatment plan is working and whether adjustments are needed.
The Kidney Failure Risk Equation calculator provides an accessible way to quantify your short-term risk of progressing to end-stage kidney disease. By entering your age, eGFR, ACR, and sex, you receive a rough percentage that can inform discussions with your healthcare team. While not a substitute for professional medical advice, it can offer valuable insight into the trajectory of chronic kidney disease and highlight the importance of early, proactive management.
Compute mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and mean corpuscular hemoglobin concentration (MCHC) from blood count values.
Calculate corrected QT interval (QTc) using Bazett and Fridericia formulas to evaluate arrhythmia risk.
Estimate a new weekly warfarin dose based on current INR and target INR. Always consult your clinician before changing medications.